Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$2.22B |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$2.02B |
| 3 |
Amazon
AMZN
|
+$1.98B |
| 4 |
EPAM Systems
EPAM
|
+$1.88B |
| 5 |
Apple
AAPL
|
+$1.57B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$3.27B |
| 2 |
Netflix
NFLX
|
+$2.99B |
| 3 |
Microsoft
MSFT
|
+$1.94B |
| 4 |
Home Depot
HD
|
+$1.69B |
| 5 |
CSX Corp
CSX
|
+$1.11B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.08% |
| 2 | Healthcare | 14.23% |
| 3 | Consumer Discretionary | 12.89% |
| 4 | Financials | 10.35% |
| 5 | Industrials | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Lam Research
LRCX
$418B
| $177M | 0.04% |
3,297,950
-304,300
| -8% | -$17.7M |
|
252
Icon
ICLR
$12.8B
| $177M | 0.04% |
726,397
-193,555
| -21% | -$48.5M |
|
253
Patria Investments
PAX
$1.84B
| $174M | 0.04% |
9,771,580
+4,750,000
| +95% | +$79.1M |
|
254
Pegasystems
PEGA
$5.27B
| $173M | 0.04% |
4,285,094
+2,329,162
| +119% | +$104M |
|
255
CONMED
CNMD
$1.48B
| $169M | 0.04% |
1,139,356
+12,300
| +1% | +$1.72M |
|
256
Merck
MRK
$332B
| $167M | 0.04% |
2,036,976
+1,029
| +0.1% | +$81.1K |
|
257
Coursera
COUR
$1.5B
| $167M | 0.04% |
7,253,098
| – | – |
|
|
EVRI
258
DELISTED
Everi Holdings
EVRI
| $163M | 0.04% |
7,758,438
-463,650
| -6% | -$9.87M |
|
|
JHG
259
DELISTED
Janus Henderson
JHG
| $161M | 0.04% |
4,603,276
-3,062,229
| -40% | -$110M |
|
260
Suncor Energy
SU
$75.2B
| $158M | 0.04% |
4,858,879
-8,826
| -0.2% | -$262K |
|
261
New York Times
NYT
$10.3B
| $158M | 0.04% |
3,450,512
+1,267
| +0% | +$54.9K |
|
262
Weatherford International
WFRD
$6.63B
| $157M | 0.04% |
4,726,247
-5,516
| -0.1% | -$173K |
|
263
Public Storage
PSA
$60.9B
| $156M | 0.04% |
400,000
| – | – |
|
|
ATCO
264
DELISTED
Atlas Corp.
ATCO
| $156M | 0.04% |
10,609,768
+2,266,500
| +27% | +$33.6M |
|
265
StoneCo
STNE
$2.48B
| $155M | 0.04% |
13,262,194
-23,888,852
| -64% | -$312M |
|
266
Chegg
CHGG
$86M
| $151M | 0.04% |
4,165,030
-80,042
| -2% | -$2.41M |
|
267
Playtika
PLTK
$931M
| $151M | 0.04% |
7,792,781
-1,896,040
| -20% | -$33.7M |
|
268
DraftKings
DKNG
$12.7B
| $149M | 0.04% |
7,630,800
-4,003,213
| -34% | -$85M |
|
269
Johnson & Johnson
JNJ
$629B
| $147M | 0.04% |
827,379
+19
| +0% | +$3.23K |
|
270
Euronet Worldwide
EEFT
$2.69B
| $146M | 0.04% |
1,122,002
+103,786
| +10% | +$13.2M |
|
271
Herbalife
HLF
$1.27B
| $146M | 0.04% |
4,802,262
-3,330,028
| -41% | -$130M |
|
272
SS&C Technologies
SSNC
$18.9B
| $146M | 0.04% |
1,941,696
-112,911
| -5% | -$8.83M |
|
|
ONT
273
Onterris Inc
ONT
$579M
| $143M | 0.04% |
2,699,774
+519,892
| +24% | +$25.7M |
|
274
BOK Financial
BOKF
$8.83B
| $143M | 0.04% |
1,519,879
-1,569
| -0.1% | -$162K |
|
275
BWX Technologies
BWXT
$15.5B
| $142M | 0.04% |
2,632,834
+211,329
| +9% | +$10.4M |
|
Similar funds
Capital Research Global Investors's Q1 2022 Portfolio in Review
As of Q1 2022, Capital Research Global Investors held 468 positions worth $405B, down 11% from $453B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Capital Research Global Investors's Q1 2022 filing shows 28 new, 180 increased, 190 reduced and 28 closed positions. Its largest new stake was Halliburton: 17,891,897 shares worth $678M. The largest sale was Gilead Sciences, an estimated $3.27B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Capital Research Global Investors's largest Q1 2022 buy was Halliburton: 17,891,897 shares worth $678M.
- Capital Research Global Investors added most to GE Aerospace in Q1 2022, an estimated $2.22B increase.
- Capital Research Global Investors's biggest Q1 2022 reduction was Gilead Sciences, cutting an estimated $3.27B.
- Capital Research Global Investors fully exited PayPal in Q1 2022, selling an estimated $769M.
- Capital Research Global Investors's ten largest holdings make up 28% of its $405B portfolio in Q1 2022.
- Capital Research Global Investors opened 28 new positions and closed 28 in Q1 2022.
- Capital Research Global Investors's portfolio value fell 11% quarter-over-quarter to $405B.
Based on Capital Research Global Investors's 13F filing for Q1 2022, filed 16 May 2022.